Patient Square Capital has led a series B round for the Stanford-linked gene therapy developer, which previously collected $80.5m in May last year.

Technion-linked cultured meat developer has raised a series B round that took its overall funding to $118m.

Congruent Ventures has returned for a $50m series B round that will allow Meati to complete a commercial production plant in time for a market launch next year.

Tyson Foods has thrown its weight behind Harvard spinout Soft Robotics to bring the series B total to $33m.

4490 Ventures has reinvested in Trainual, participating in a $27m series B round a year and a half after having co-led the series A.

Mission Bay Capital, the venture capital arm of California Institute for Quantitative Biosciences, helped the replacement therapy developer close its series B round.

The Cornell cardiovascular data technology spinout has launched with $54m in funding, $43m coming from an American College of Cardiology-backed series B round.

Nutreco and Olympic Investments co-led a $49.8m round for the mycoprotein ingredient developer and University of Strathclyde spinout that included Axa.

Umoja Biopharma, based on research at Purdue University and Seattle Children’s Research Institute, has picked up a series B co-led by SoftBank Vision Fund 2.

Motif FoodWorks, which traces its roots to MIT, has pocketed $226m in a round backed by returning investor Louis Dreyfus a month after Motif’s parent agreed to a reverse merger.